We don’t followthe longevity field.We’re building it.

Research-grade longevity testing, your results tracked over time, a guided program and private community, and priority access to cutting-edge clinical trials as they launch.

Founding membership, pricing locked for 3 years. Limited to first 100 members.

Science. Longevity. Life.

Biomarkers assessed
100+
Geroprotective trials
Upcoming
Doctors & longevity scientists
Science-led
Founding member spots
100

Your Membership

Your health has a future.
We're building the science to shape it.

We track how you're ageing over time, and build the research that brings our members the latest in cutting-edge longevity science.

Biomarker range

4 tests

ABOVEIN RANGEBELOW16.710.012.511.2

Know how you’re really ageing

100+ biomarkers, including the longevity markers most clinics miss.

Now playing · Course 1

Why the Blue Zones are mostly fiction

Up nextVO2max: why fitness predicts everything

The science, without the hype

Evidence-based education and a private community, led by longevity scientists.

Upcoming

Research program

Priority access · Members first

Priority access to the frontier

Be first in line for cutting-edge clinical trials as they launch.

01

The Process

01Enrolment

Join as a founding member

Choose your membership tier and join online. Founding member pricing is locked at the rate you join at for 3 years, regardless of future price increases.

Founding membership from $1,499 a year, pricing locked for 3 years.

Research & Science

We don't wait for
the science to arrive.
We make it.

AIHL is building its geroprotective research program with research partners, investigating interventions that may slow, halt, or reverse aspects of biological ageing.

Founding members will get priority access to participate in these trials as they launch, where eligible, putting them at the leading edge of what the field is learning.

Multi-omicsResearch depth, layer by layer
TranscriptomicsSingle-cell & spatial RNA
ProteomicsSpatial protein analysis
Immune profilingImmune cells & cytokines
Genomics & epigenomicsDNA & ageing clocks
MetagenomicsGut microbiome
Upcoming
Our first geroprotective study

Designed with research partners, and run only after independent ethics approval. Founding members will hear first.

Research access
Study runsWith research partners
Members notifiedPre-publication
Public releaseJournal / media
Research partnersConfirming partners
EthicsIndependent ethics review
AccessFounding members first
UpdatesMembers notified first

Membership Access

Longevity science, made personal.

01Diagnostic depth

100+ biomarker panel

A research-grade panel across metabolic health, advanced lipids, inflammation, hormones and organ function, with advanced longevity markers in Tiers 2 and 3.

Well beyond the standard check-up.

Biomarker panel100+
02Ageing signals

How you’re ageing, in context

Biological age is complex, and no single test captures it. We track validated estimates such as PhenoAge alongside the individual markers behind them, so you see the whole picture.

Many signals, not one number.

Ageing signals

PhenoAge estimateOne validated model
Inflammationhs-CRP, IL-6
MetabolicHbA1c, insulin
Organ functionKidney, liver

No single number captures how you age.

03Trial access

Priority access to upcoming trials

As AIHL’s geroprotective research program opens, founding members will hear first and be invited to take part in studies where eligible.

Founding members first in line.

Upcoming

AIHL geroprotective research program

StatusIn development
EthicsIndependent ethics review
AccessFounding members first

Participation always voluntary

04Your record

Personal longitudinal dashboard

Every biomarker from every test, tracked against reference ranges in one record. It becomes more valuable with every test.

A standing record, not a one-off result.

Longitudinal record18 mo
M0M3M6M9M12M15M18
05Living science

Education that updates with the science

Your course library and member briefings are updated as peer-reviewed evidence moves, so what you learn reflects the current science.

Updated with the evidence, not the news cycle.

Evidence updatesThis quarter
NewResearch brief: what’s new in senolytics
NewLesson: VO2max and why fitness predicts longevity
UpdatedApoB and cardiovascular risk, 2026 evidence
UpdatedProtein needs across the lifespan
06Standing

Founding cohort standing

Limited to the first 100 members, with pricing locked for 3 years and first access to the research program as it opens.

First in.

Founding cohort

100spots
Pricing locked3 years
Research accessFirst in line
CommunityFounding cohort

Membership tiers

Choose the level of
depth you want

Founding member pricing is locked at the rate below for your first 3 years — regardless of future price increases.

Tier 1
$124.92/mo
$1,499 per year

Founding member rate — locked for 3 years

Annual comprehensive screening across core longevity biomarkers, general guidance on your results, your personal dashboard, and the AIHL Longevity Education Program.

  • PhenoAge biological age estimate
  • Core blood panel: metabolic, lipids, glucose, HbA1c & insulin
  • Thyroid function & inflammatory markers (hsCRP, ESR)
  • Annual DEXA body composition scan
  • AIHL Longevity Education Program
  • General guidance on your results
  • Personal dashboard with wearable integration
  • Private member community
  • Priority access to upcoming trials
Tier 2Most popular
$250/mo
$3,199 per year·$449 first month

Founding member rate — locked for 3 years

Everything in Tier 1, plus an expanded panel covering micronutrients, hormones, advanced cardiovascular markers, and longevity research biomarkers.

  • Everything in Tier 1
  • Expanded micronutrient panel (iron, B12, folate, zinc, copper, Vit D)
  • Full sex hormone panel
  • Omega Index, ApoB/A1 & homocysteine
  • Longevity cytokine panel (TNF, TGF, IL-6, IL-11, GDF15)
Tier 3
$550/mo
$6,999 per year·$949 first month

Founding member rate — locked for 3 years

Our most comprehensive assessment. Adds Klotho, epigenetic age testing, ApoE genotyping, and extended hormonal and metabolic profiling.

  • Everything in Tier 2
  • Extended metabolic & cardiovascular (Lp(a), cystatin C, OGTT)
  • Advanced hormonal panel (GH, IGF-1, cortisol, DHEA)
  • Klotho & NAD+ levels
  • TruAge epigenetic age testing
  • ApoE genotyping
  • Annual doctor review

AIHL provides screening, education and community. It does not diagnose or treat medical conditions, and complements your GP rather than replacing them. Pricing shown in AUD.

Longevity, measured

Measure it. Track it.
Understand it.

Longevity isn't a single test. It's a record of how you change over time, and the knowledge to make sense of it.

A member reviewing their biomarker trends on a phone at home, golden hour by the coast

Why AIHL

How we differ fromwhat already exists

Recommended
AIHL
Standard
GP
Executive
Health Check
100+ biomarker comprehensive panel
Research-grade longevity biomarkers
Ageing signals, including PhenoAge, tracked over time
Longitudinal tracking & analytics dashboard
Wearable connection and tracking
Evidence-based longevity education & guidance
Annual doctor review (Tier 3)
Evidence-based longevity education program
Private member community
Priority access to upcoming longevity trials
Access advanced add-on tests
Pricing locked at founding rate for 3 years
Included
Partial / varies
Not included

The Team

Clinicians and Scientists,
committed to the science

AIHL is led by clinicians and scientists who work in longevity, not adjacent to it. The people who set our testing standards are the same people building our research program.

Simon Baarbé

Simon Baarbé, MD BESc

Chief Medical Officer

Physician–engineer translating geroscience into rigorous, evidence-based prevention.

Learn more
Nic West

Nic West, PhD

Chief Scientific Officer

Associate Professor at Griffith University researching immune ageing, inflammation and the microbiome.

Learn more
Richard Gabbrielli

Richard Gabbrielli, MPhty

Chief Executive Officer

Physiotherapist and health entrepreneur, building an institute where longevity science is held to evidence.

Learn more

Scientific Perspectives

What leading researchers
say about our approach

Professor Pete Smith
Longevity medicine is rich in emerging science, yet largely shaped by influencers and commercial interests rather than the rigour patients deserve. Translating the best available science into a rigorous, clinically grounded methodology — disciplined, honest and clinician-led — may be the most important contribution academic medicine can make to human health in a generation.

Professor Pete Smith, BMedSci, MBBS, FRACP, PhD

Allergist and Immunologist

Matt Kaeberlein
AIHL represents the shift preventive health has long needed — from reactive care to a science-based approach built on longitudinal biomarker tracking and personalized intervention. The panel itself reflects real scientific judgment with established relevance to biological age trajectory, not a consumer wellness checklist. Pairing that with real research access, including geroprotective trials, is the kind of rigor this field needs more of.

Matt Kaeberlein, PhD

Biogerontologist

Former Professor, University of Washington

FAQ

Common questions

Founding Membership

Your place at the frontier
starts on the waitlist.

Founding memberships open in October. The first 100 members get pricing locked for 3 years, and waitlist members are first in line.

Founding membership — limited to first 100 members

Joining the waitlist is free, with no obligation to buy.